Your browser is no longer supported. Please, upgrade your browser.
Settings
AXN Aoxing Pharmaceutical Company, Inc. daily Stock Chart
AXN [NYSE]
Aoxing Pharmaceutical Company, Inc.
Index- P/E- EPS (ttm)-0.02 Insider Own42.05% Shs Outstand76.07M Perf Week0.47%
Market Cap24.34M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float47.10M Perf Month-8.57%
Income-1.50M PEG- EPS next Q- Inst Own0.40% Short Float0.52% Perf Quarter-23.81%
Sales30.10M P/S0.81 EPS this Y-68.60% Inst Trans16.01% Short Ratio3.59 Perf Half Y-11.11%
Book/sh0.25 P/B1.28 EPS next Y- ROA-2.50% Target Price4.00 Perf Year-48.67%
Cash/sh0.09 P/C3.43 EPS next 5Y- ROE-7.60% 52W Range0.30 - 0.94 Perf YTD-0.03%
Dividend- P/FCF- EPS past 5Y16.80% ROI12.50% 52W High-65.96% Beta3.30
Dividend %- Quick Ratio0.70 Sales past 5Y37.20% Gross Margin76.20% 52W Low6.67% ATR0.03
Employees339 Current Ratio0.80 Sales Q/Q-13.60% Oper. Margin3.20% RSI (14)42.10 Volatility8.01% 10.04%
OptionableNo Debt/Eq1.45 EPS Q/Q-79.00% Profit Margin-4.90% Rel Volume0.56 Prev Close0.30
ShortableYes LT Debt/Eq0.01 EarningsMay 22 BMO Payout- Avg Volume68.12K Price0.32
Recom1.00 SMA20-5.32% SMA50-11.24% SMA200-23.64% Volume38,322 Change5.33%
May-26-17 09:19AM  Aoxing Pharmaceutical Co., Inc. :AXN-US: Earnings Analysis: Q3, 2017 By the Numbers : May 26, 2017 Capital Cube
May-15-17 04:30PM  Aoxing Pharmaceutical Reports Q3 Fiscal 2017 Financial Results Accesswire
09:06AM  Aoxing posts 3Q profit Associated Press
Mar-08-17 12:05PM  Aoxing Pharmaceutical Co., Inc. :AXN-US: Earnings Analysis: Q2, 2017 By the Numbers : March 8, 2017 Capital Cube
12:05PM  Aoxing Pharmaceutical Co., Inc. :AXN-US: Earnings Analysis: Q2, 2017 By the Numbers : March 8, 2017
Feb-23-17 01:04PM  AOXING PHARMACEUTICAL COMPANY, INC. Financials +5.36%
Feb-17-17 12:34PM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q/A, Quarterly Report
Feb-14-17 05:41PM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly Report
04:30PM  Aoxing Pharmaceutical Reports Q2 Fiscal 2017 Financial Results Accesswire
Nov-14-16 05:07PM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly Report +8.89%
04:30PM  Aoxing Pharmaceutical Reports Q1 Fiscal 2017 Financial Results Accesswire
Oct-17-16 09:17PM  Aoxing Hits Another 52-Week Low (AXN) Investopedia -8.16%
09:17PM  Aoxing Hits Another 52-Week Low (AXN) at Investopedia
Oct-10-16 04:30PM  Aoxing Pharmaceutical Company, Inc. Receives Audit Opinion with Going Concern Qualification Accesswire
Oct-06-16 05:50PM  Aoxing Pharmaceutical Reports 2016 Results (AXN) Investopedia -6.03%
05:50PM  Aoxing Pharmaceutical Reports 2016 Results (AXN) at Investopedia
Oct-05-16 04:33PM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-K, Annual Report
04:30PM  Aoxing Pharmaceutical Reports Fiscal 2016 Financial Results Accesswire
Sep-29-16 01:14PM  Aoxing Pharmaceutical Delays 10-K Filing (AXN) Investopedia
01:14PM  Aoxing Pharmaceutical Delays 10-K Filing (AXN) at Investopedia
Jul-08-16 04:19PM  Aoxing Pharmaceutical Co., Inc.: Price momentum supported by strong fundamentals Capital Cube -12.26%
04:19PM  Aoxing Pharmaceutical Co., Inc.: Price momentum supported by strong fundamentals
Jun-30-16 11:29AM  Aoxing Pharmaceutical Starts producing Tilidine Hydrochloride Tablets Benzinga
08:30AM  Aoxing Pharma Commences Production of Tilidine Hydrochloride Tablets Accesswire
Jun-23-16 07:56AM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-17-16 02:02PM  Aoxing Pharmaceutical Co., Inc. :AXN-US: Earnings Analysis: Q3, 2016 By the Numbers
May-16-16 08:00AM  Aoxing Pharmaceutical Reports Q3 Fiscal 2016 Financial Results Marketwired -5.44%
07:34AM  Aoxing posts 3Q profit
07:06AM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly Report
Feb-11-16 10:54AM  Aoxing Pharmaceutical Co., Inc. Earnings Analysis: Q2, 2016 By the Numbers
Feb-08-16 09:24AM  Aoxing posts 2Q profit -22.50%
08:30AM  Aoxing Pharmaceuticals Q2 Revenue Up 27%; Net Income $2.1 Million, Up 265% PR Newswire
08:18AM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly Report
Feb-01-16 08:30AM  Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer PR Newswire
06:05AM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Financial Statements and Exhibits
Dec-21-15 10:38AM  Aoxing Pharmaceutical Co., Inc. Earnings Analysis: Q1, 2016 By the Numbers
Dec-10-15 08:30AM  Aoxing Pharma Selected to Supply Zhongtongan to the Insurance System for the City of Shanghai PR Newswire +7.92%
Dec-04-15 08:30AM  Aoxing Pharma Announces Opening Of Government Funded Drug Research Center PR Newswire
08:00AM  Aoxing Pharma Announces Resignation of CFO PR Newswire
Dec-03-15 10:38AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aoxing Pharmaceutical Company, Inc. PR Newswire -10.16%
Dec-02-15 06:27PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aoxing Pharmaceutical, Inc. - AXN PR Newswire -6.57%
Dec-01-15 04:52PM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Nov-13-15 11:47AM  Aoxing Pharmaceuticals (AXN) Stock Spikes Following Earnings Release at TheStreet +6.06%
11:27AM  Why Are Investors Piling Into These Four Stocks? at Insider Monkey
08:35AM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly Report
08:30AM  Aoxing Pharmaceuticals Q1 Revenue Up 92 Percent; Net Income Of $1.35 Million PR Newswire
Nov-04-15 08:31AM  Aoxing Pharma Gains Inclusion of Xiongju Shangqing Tablet in Essential Drug Procurement List of Nine Provinces in China Accesswire
Oct-21-15 11:12AM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Regulation FD Disclosure
Oct-20-15 11:30AM  Aoxing Pharma Receives China FDA Approval to Initiate Four Programs for Controlled Substances Accesswire
Oct-16-15 09:00AM  Aoxing Pharmaceutical Company to Host Investor Luncheons in Dallas, San Francisco and San Diego Accesswire +6.34%
Oct-13-15 01:20PM  Why Did These Stocks Move Higher On Tuesday And Should You Follow The Crowd? at Insider Monkey -13.46%
11:13AM  Aoxing Pharmaceutical (AXN) Stock Spikes After Announcing Full Year Net Income at TheStreet
07:00AM  Aoxing Pharma Announces Fiscal 2015 Net Income of $5.8 Million vs. $8.6 Million Net Loss in Fiscal 2014 Marketwired
06:35AM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-K, Annual Report
Oct-12-15 09:00AM  Aoxing Pharmaceutical Company to Host Live Conference Call and Webcast on Tuesday, October 13, 2015, 8:30am EDT Accesswire -6.02%
Oct-02-15 08:30AM  Aoxing Pharma to Announce Fiscal 2015 Financial Results, Host Webcast and Conference Call Oct. 13 at 8:30 AM Eastern Accesswire
Oct-01-15 06:03AM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Stateme
Sep-25-15 08:01AM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Stateme -5.75%
08:00AM  Aoxing Pharmaceutical Announces $3 Million Registered Direct Offering Accesswire
Sep-23-15 09:58AM  Aoxing Pharmaceutical Co., Inc. breached its 50 day moving average in a Bullish Manner : September 23, 2015
Sep-16-15 08:30AM  Aoxing Pharma Gains Inclusion of Zhongtongan in Procurement Lists of Hebei, Jiangsu, Shanxi, and Hubei Provinces Accesswire
Sep-10-15 08:30AM  Aoxing Pharma Enters into Cooperative Agreement to Reinitiate its Pill Production Accesswire +5.56%
Jul-23-15 11:49AM  5 Health Care Stocks Under $10 Set to Soar at TheStreet
Jul-21-15 02:03PM  3 Stocks Under $10 Triggering Breakout Trades at TheStreet
Jul-13-15 12:58PM  Monday's Mid-Day Movers: Greece Reaches Deal, Dow Up Triple Digits +23.74%
11:30AM  Aoxing Pharmaceutical (AXN) Stock Gains After Positive Opioid Addiction Treatment Results at TheStreet
08:37AM  Aoxing Pharma Announces Positive Results of Registration Trial of Buprenorphine/Naloxone Sublingual Tablets as a Treatment of Opioid Dependence Accesswire
Jun-29-15 08:30AM  Aoxing Pharmaceutical Company, Inc. Granted Certification of High and New-Technology Enterprise Accesswire -6.88%
Jun-23-15 02:55PM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -13.00%
Jun-10-15 12:00PM  Aoxing Pharmaceutical (AXN) Stock Plummeting to Reverse Yesterday's Gains at TheStreet
Jun-08-15 05:50PM  Aoxing Pharmaceutical Company, Inc. Announces Receipt Of License To Produce Tilidine HCL Tablet Accesswire
Jun-06-15 11:05AM  Aoxing Pharmaceutical Company (NYSE:AXN) to Announce Important Company Updates at New York Stock Exchange GlobeNewswire
Jun-04-15 11:51AM  5 Stocks Under $10 Set to Soar Higher at TheStreet
Jun-02-15 01:57PM  4 Stocks Under $10 to Trade for Big Breakouts at TheStreet
May-27-15 10:40AM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Regulation FD Disclosure
May-20-15 08:30AM  Aoxing Pharmaceutical Company to Host Investor Luncheons in New York City and Boston Accesswire
May-18-15 08:12PM  10-Q for Aoxing Pharmaceutical Co., Inc. at Company Spotlight
May-15-15 01:30PM  Aoxing Pharmaceutical Company, Inc. Announces Financial Results for Third Quarter of 2015 Fiscal Year Accesswire
12:05PM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly Report
08:30AM  Tilidine Tablet Enters CFDA Production Registration Review Accesswire
Apr-27-15 09:00AM  Aoxing Pharmaceutical Company, Inc. Regains Full Compliance with NYSE MKT Listing Standards Accesswire
Apr-23-15 05:00PM  NYSE MKT Gives Conditional Notice to Aoxing Pharmaceutical Company, Inc. That It Has Regained Compliance with Continued Listing Requirements Accesswire
Apr-03-15 02:59PM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Other Events
01:10PM  NYSE MKT Notifies Aoxing Pharmaceutical Company, Inc. That It Has Regained Compliance with a Financial Condition Requirement Accesswire
Mar-30-15 04:15PM  Aoxing Pharmaceutical Company, Inc. Receives GMP Certification Accesswire
Mar-13-15 09:39AM  Aoxing Pharmaceutical Company, Inc. Announces Private Sale of Common Stock Accesswire
Mar-12-15 01:35PM  3 Health Care Stocks Under $10 to Trade for Breakouts at TheStreet
Feb-19-15 07:07PM  10-Q for Aoxing Pharmaceutical Co., Inc. at Company Spotlight
Feb-17-15 10:06AM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly Report
08:00AM  Aoxing Pharmaceutical Company, Inc. Announces Financial Results for Second Quarter of 2015 Fiscal Year Accesswire
Feb-09-15 08:30AM  Aoxing Pharmaceutical Company, Inc. Announces Private Sale of Common Stock Accesswire
Jan-30-15 01:50PM  NYSE Market Notifies Aoxing Pharmaceutical Company, Inc. of Extension of Time for Compliance Accesswire
11:59AM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing
Jan-16-15 01:42PM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing
01:15PM  NYSE Market Notifies Aoxing Pharmaceutical Company, Inc. Of Extension of Time for Compliance Accesswire
Dec-29-14 08:45AM  Aoxing Pharmaceutical Company, Inc. Announces Appointment of CFO and Independent Director Accesswire
08:19AM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statemen EDGAR Online
Dec-19-14 03:47PM  NYSE MKT Notifies Aoxing Pharmaceutical Company, Inc. of Extension of Time For Compliance Accesswire
03:21PM  AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing EDGAR Online
Nov-17-14 07:09PM  10-Q for Aoxing Pharmaceutical Co., Inc. Company Spotlight
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. was founded in 1655 and is headquartered in Shijiazhuang, China.